These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12658770)

  • 21. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
    Videla-Rivero L; Etchepareborda JJ; Kesseru E
    Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium.
    Coskun E; Cakiroglu Y; Aygun BK; Muezzinoglu B; Caliskan E
    Contraception; 2011 Dec; 84(6):637-41. PubMed ID: 22078195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between copper IUD complications and ultrasonographic findings.
    Fadiloglu S; Dilbaz B; Fadiloglu E; Dilbaz S
    Arch Gynecol Obstet; 2018 Apr; 297(4):989-996. PubMed ID: 29428979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reasons for removal of intrauterine devices among women in general practice].
    Kolding L; Majeed HG
    Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of herb therapy for benefiting qi and removing blood stasis on ultrastructure of vascular endothelial cells and vascular smooth muscle cells of uterine endometrium in rabbits with copper intrauterine device].
    Lei L; You ZL; Fu LM; Wen LX
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):60-3. PubMed ID: 16409973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the reason of abnormal uterine bleeding induced by copper corrosion of IUD Cu.
    Li L; Li J; Li N; Zhang Y; Feng X
    Clin Exp Obstet Gynecol; 2016; 43(6):883-886. PubMed ID: 29944244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicated intrauterine devices: development considerations and clinical uses.
    Chien YW
    J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional power Doppler study of endometrial and subendometrial microvascularization in women with intrauterine device-induced menorrhagia.
    El-Mazny A; Abou-Salem N; Elshenoufy H
    Fertil Steril; 2013 Jun; 99(7):1912-5. PubMed ID: 23465819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study.
    Barnett C; Moehner S; Do Minh T; Heinemann K
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):424-428. PubMed ID: 29322856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K; Batar I; Rybo G
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IUD and endometrial bleeding.
    Rybo G
    J Reprod Med; 1978 Mar; 20(3):175-82. PubMed ID: 347075
    [No Abstract]   [Full Text] [Related]  

  • 40. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
    Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.